Celebrating 40 Years of Progress in Bone Marrow Transplantation: A Report from the 40th Annual Meeting of the European Society for Blood and Marrow Transplantation

References

• Lortholary O , GangneuxJP , SitbonKet al. Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005–2007) . Clin. Microbiol. Infect.17 ( 12 ), 1882 – 1889 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Nucci M , Queiroz-TellesF , Alvarado-MatureTet al. Epidemiology of candidemia in Latin America: a laboratory-based survey . PloS ONE6 ( 8 ), e59373 ( 2013 ).
   Google Scholar
• WBMT (Worldwide Network for Blood and Marrow Transplantation) . 1 Millionth blood stem cell transplant marks major medical milestone . http://.wbmt.org/fileadmin/pdf/01_General/Press_release_final.pdf .
   Google Scholar
• Bazuaye NG , EnomamienB . Hematopoietic stem cell transplantation (HSCT) for hemoglobinopathy (sickle cell disease) in Nigeria – 2013 update by Nigerian Group for Blood and Marrow Transplant (NGBMT) . Bone Marrow Trans.49 ( Suppl. 1 ), PH-P459 ( 2014 ).
   Google Scholar
• Pagano L , CairaM , CandoniAet al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study . Haematologica91 ( 8 ), 1068 – 1075 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Pagano L , CairaM , NosariAet al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study – Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne . Clin. Infect. Dis.45 ( 9 ), 1161 – 1170 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Pagano L , CairaM , CandoniAet al. Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study . Haematologica95 ( 4 ), 644 – 650 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Caira M , CandoniA , BuscaLet al. Pre-hospital risk factors for invasive fungal disease in newly diagnosed acute myeloid leukaemia: final results from SEIFEM 2010-A PR . Presented at : 23rd European Congress on Clinical Microbiology and Infectious Diseases (ECCMID) . Berlin, Germany , 30 April, 2013 .
   Google Scholar
• Cornely OA , MaertensJ , WinstonDJet al. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia . N. Engl. J. Med.356 ( 4 ), 348 – 359 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Ullmann AJ , LiptonJH , VesoleDHet al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease . N. Engl. J. Med.356 ( 4 ), 335 – 347 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Pagano L , CairaM , CandoniAet al. Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry . Clin. Infect. Dis.55 ( 11 ), 1515 – 1521 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Kleinkauf N , VerweijP , ArendrupMet al. European Centre for Disease Prevention and Control. Risk assessment on the impact of environmental usage of triazoles on the development and spread of resistance to medical triazoles in Aspergillus species . ECDC , Stockholm, Germany ( 2013 ).
   Google Scholar
• Hamprecht A , BuchheidtD , VehreschildJJet al. Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in Germany . Euro. Surveill.17 ( 36 ), 20262 ( 2012 ).
   PubMedGoogle Scholar
• Seyedmousavi S , BruüggemannRJ , MelchersWJet al. Posaconazole prophylaxis in experimental azole resistant invasive pulmonary aspergillosis . Presented at : 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) . Denver, Colorado, USA , 10 – 13 , September 2013 .
   Google Scholar
• Seyedmousavi S , BruüggemannRJ , MelchersWJet al. Intrapulmonary posaconazole penetration at the infection site in an immunosuppressed murine model of invasive pulmonary aspergillosis receiving oral prophylactic regimens . Antimicrob. Agents Chemother.58 ( 5 ), 2964 – 2967 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Auberger J , Lass-FlöriC , AignerMet al. Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study . J. Antimicrob. Chemother.67 ( 9 ), 2268 – 2273 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Strasfeld L , Espinosa-AguilarL , GajewskiJLet al. Emergence of Cunninghamella as a pathogenic invasive mold infection in allogeneic transplant recipients . Clin. Lymphoma Myeloma Leuk.13 ( 5 ), 622 – 628 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Park B , PappasPG , WannemuehlerKAet al. Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001–2006 . Emerg. Infect. Dis.17 ( 10 ), 1855 – 1864 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Legouge C , CaillotD , ChrétienMLet al. The reversed halo sign: pathognomonic pattern of pulmonary mucormycosis in leukemic patients with neutropenia? Clin. Infect. Dis. 58 ( 5 ), 672 – 678 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Hammond SP , BialekR , MilnerDAet al. Molecular methods to improve diagnosis and identification of mucormycosis . J. Clin. Microbiol.49 ( 6 ), 2151 – 2153 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Skiada A , PaganoL , GrollAet al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007 . Clin. Microbiol. Infect.17 ( 12 ), 1859 – 1867 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Chamilos G , LewisRE , KontoyiannisDP . Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis . Clin. Infect. Dis.47 ( 4 ), 503 – 509 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Herbrecht R , TissotF , AgrawalSet al. 2013-update of the ECIL Guidelines for Antifungal Therapy in Leukemia and HSCT Patients (ECIL-5) . Presented at : 5th European Conference on Infections in Leukaemia . Sophia Antipolis, France , 20–21 September 2013 .
   Google Scholar